Ryan Tactac

Developing effective treatments for cancer involves a lot more than just the science—it’s economics, too. March 6 marked the one-year anniversary of the Food and Drug Administration (FDA)’s approval of Zarxio, a revolutionary 21st-century medicine used to save cancer patients from lethal infections. Unfortunately, we may be seeing less and less progress on this front…